VYNE Therapeutics Stock Forecast

Stock Price Forecast

The 2 analysts with 12-month price forecasts for VYNE Therapeutics stock have an average target of 6.88, with a low estimate of 5.75 and a high estimate of 8.00. The average target predicts an increase of 335.44% from the current stock price of 1.58.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$5.75	$6.88	$8.00	$8.00
Change	+263.92%	+335.44%	+406.33%	+406.33%

Analyst Ratings

The average analyst rating for VYNE Therapeutics stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Oct '24	Nov '24	Dec '24	Jan '25	Feb '25	Mar '25
Strong Buy	1	2	2	2	2	2
Buy	0	0	0	0	0	0
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	1	2	2	2	2	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Joseph Pantginis HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $5.75	Strong Buy	Reiterates	$5.75	+263.92%	Mar 6, 2025
Joseph Pantginis HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $5.75	Strong Buy	Reiterates	$5.75	+263.92%	Feb 19, 2025
Joseph Pantginis HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $5.75	Strong Buy	Reiterates	$5.75	+263.92%	Jan 14, 2025
Joseph Pantginis HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $5.75	Strong Buy	Reiterates	$5.75	+263.92%	Jan 6, 2025
Joseph Pantginis HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $5.75	Strong Buy	Reiterates	$5.75	+263.92%	Dec 23, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

255.00K

from 501.00K

-49.10%

from 501.00K

Revenue Next Year

306.00K

from 255.00K

20.00%

from 255.00K

EPS This Year

-1.20

from -0.94

EPS Next Year

-1.06

from -1.20

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	20.99M	931.00K	477.00K	424.00K	501.00K	255.00K	306.00K	-
Revenue Growth	4,638.83%	-95.57%	-48.77%	-11.11%	18.16%	-49.10%	20.00%	-
EPS	-141.90	-25.65	-7.28	-2.78	-0.94	-1.20	-1.06	-0.83
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	4	4	3

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	525,000	630,000	n/a
Avg	255,000	306,000	n/a
Low	n/a	n/a	n/a

Revenue Growth

Revenue Growth	2025	2026	2027
High	4.8%	147.1%	-
Avg	-49.1%	20.0%	-
Low	-	-	-

EPS Forecast

EPS	2025	2026	2027
High	-1.23	-0.79	-0.85
Avg	-1.20	-1.06	-0.83
Low	-1.16	-1.29	-0.79

EPS Growth

EPS Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.